Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: The Effect of Probiotic Combination on Helicobacter Pylori Infection in Children [NA]
The clinical trial evaluating a probiotic combination for Helicobacter pylori infection in children has been withdrawn by the sponsor (Unive…
-
FDA approval · 2017-08-18FDA Approved: KIRKLAND SIGNATURE ESOMEPRAZOLE MAGNESIUM — Original Application (Costco Wholesale Company)
The FDA approved the original generic application for Kirkland Signature Esomeprazole Magnesium, a generic version of esomeprazole magnesium…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication [NA]
A completed clinical trial comparing hybrid therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection, with results p…
-
FDA approval · 2017-07-06FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth/Pfizer to update the drug's labeling.
-
FDA approval · 2017-07-05FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Original Application (BJWC)
FDA approved Berkley and Jensen Omeprazole under an original application; the product is a proton pump inhibitor indicated for gastroesophag…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-07-05Clinical Trial Update: Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection [NA]
This is a clinical trial comparing PCR-guided triple therapy for Helicobacter pylori eradication versus empiric concomitant quadruple therap…
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori [Phase 3]
A Phase 3 trial comparing rabeprazole versus esomeprazole for Helicobacter pylori eradication has completed. The study evaluates comparative…
-
CLINICAL_TRIALS research · 2017-06-12Clinical Trial Update: Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection [Phase 4]
Phase 4 clinical trial comparing triple therapy versus quadruple therapies as first-line treatment for Helicobacter pylori infection. The cu…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy [Phase 4]
Phase 4 clinical trial update comparing 1- and 2-week eradication regimens for Helicobacter pylori infection; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection [Phase 4]
A Phase 4 trial comparing daily single-dose triple therapy to conventional triple therapy for Helicobacter pylori infection has completed.
-
FDA approval · 2017-05-30FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for the combination drug Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochlor…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children [NA]
A completed clinical trial evaluated the effect of adding a synbiotic to standard eradication therapy for Helicobacter pylori infection in c…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Sequential Therapy Versus Quadruple Therapy in H. Pylori Eradication [Phase 4]
Phase 4 clinical trial comparing sequential therapy versus quadruple therapy for Helicobacter pylori eradication, sponsored by National Taiw…
-
CLINICAL_TRIALS withdrawal · 2017-05-09Clinical Trial Update: Helicobacter Pylori and Body Iron in Adults [Phase 4]
A Phase 4 trial investigating the relationship between Helicobacter pylori infection and body iron in adults has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication [Phase 4]
Phase 4 clinical trial update examining genotypic resistance-guided therapy for Helicobacter pylori eradication.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study [Phase 3]
A Phase 3 clinical trial is evaluating whether Vitamin D improves eradication of drug-resistant Helicobacter pylori. The sponsor is the Chin…
-
CLINICAL_TRIALS research · 2017-05-03Clinical Trial Update: Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment [Phase 4]
This clinical trial update describes phase 4 research evaluating antimicrobial susceptibility testing-guided triple therapy for salvage trea…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication [Phase 4]
Phase 4 trial comparing 10-day versus 14-day triple therapy for Helicobacter pylori infection; current status is not specified.
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori [Phase 3]
Clinical trial update for a Phase 3 study evaluating nitazoxanide-based regimens to treat Helicobacter pylori-associated gastritis.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment [Phase 4]
Phase 4 clinical trial evaluating whether tailoring antibiotics for Helicobacter pylori infection based on antimicrobial susceptibility test…
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori [Phase 4]
A Phase 4 trial found that adding bismuth to a rabeprazole-based first-line triple therapy did not improve eradication of Helicobacter pylor…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults
A completed clinical trial assessing the prevalence of Helicobacter pylori infection in adults with intellectual and developmental disabilit…
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients
This clinical trial investigates how treatment duration and CYP2C19 genetic polymorphisms influence the eradication rate of standard triple …
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori [Phase 4]
Phase 4 clinical trial comparing 14-day triple therapy regimens using clarithromycin versus levofloxacin to eradicate Helicobacter pylori.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection [Phase 3]
Phase 3 trial update comparing Exalenz Lab Mode System to biopsy for detecting Helicobacter pylori; study completed with results posted in 2…